#ResearchLetter: Chordin-like-1 mRNA therapy for acute MI. The authors note a key advantage of mRNA therapeutics: they are amenable to straightforward clinical translation. https://t.co/IkCLAeeSrw

#Editorial highlights the evolution of TAVR procedure, and suggests that, although minimalist strategies are possible, an intermediate approach between local anesthesia alone and conscious-sedation protocols may be optimal.

This paper highlights how evolving diagnostic criteria redefine arrhythmogenic cardiomyopathy and its clinical boundaries. Author calls for refinement grounded in humility, shared decision making, and prospective studies.

Oxidized phospholipids on apo B-100 is independently associated with MACE after ACS, an effect which is attenuated with PCSK9i therapy @VeraBittner2 @gabrielsteg @DLBhattMD @W66588221White @Christa @Lpa_doc https://t.co/xThUrZQ8UK

@patrick_ellinor @joeltramo @JurgensSean

The Finnish-enriched SCN5A missense variant acted like a genetic proxy for cardiac Na channel blockade in a multi-cohort observational study with >1 million individuals. The variant can reduce the genetic liability for AFib conferred by common variants. https://t.co/0blz7W38Zb

Mitochondrial Genetics in Cardiovascular Health and Disease https://t.co/JtIMRwZCWp

Could engineered immune cells treat atherosclerosis? Anti-OxLDL CAR T regulatory cells reduced inflammation, foam-cell formation, & plaque growth in mice, without systemic side effects. A potential breakthrough in cardiovascular immunothe... @KiranMusunuru https://t.co/ZwdQALEd46

What is the ECG diagnosis? What is supernormal conduction? Learn more with this issue's #ECGChallenge! https://t.co/qjgYNEdcOb

@hiroking1975

Proteomic analysis before and after LVAD revealed key protein changes and potential recovery markers. Despite sampling differences, the IDH2/POSTN ratio predicted bridge to recovery, supporting progress toward precision medicine for heart failure with LVAD. https://t.co/tX9nMNvZV1

#Editorial: ABC-Risk Score for Reduction of Stroke and Mortality in Atrial Fibrillation by @ddbergMD

Co-published by @ACPinternists and @AHAScience #AHAJournals, @AnnalsofIMCC is a peer-reviewed, open access journal that publishes #casereports, case series, and image/video cases across the spectrum of medicine. Learn more and submit to AIMCC today at https://t.co/IzoNqdQ2Qo

#ICYMI #OriginalResearch This article details the role of A2AR-D2R dimerization and D2R-biased signaling in PDE10A-mediated cardiac hypertrophy https://t.co/LXOP5Hg2FA @coolcs1115

#ResearchLetter Cardiac MRI can be safely performed within the first week after implantation of select transvenous pacemakers, expanding early imaging options for patients with devices. 🫀📸 https://t.co/qwchvMW5EX @cardiolewis #CardioImaging #PacemakerCare

Evidence-Based Practices in the Cardiac Catheterization Laboratory: Invasive Epicardial Coronary Physiologic Assessment: A Scientific Statement From the American Heart Association

@WendyPost9 @DrLekkiWood @UtahirMD @DrPRao @Perrycardium @KajimuraLab @jravilap @ScottSummers339

N-palmitoyl glutamine and cardiorespiratory health https://t.co/NoD0CthEQl

Cardiac MRI high-risk features among individuals with tricuspid regurgitation include a TR fraction ≥40% and liver extracellular volume @sarano_maurice @PhilippLurz @hahn_rt @j_hausleiter @Miho_Fukui_ @JoaoLCavalcante https://t.co/jcM7r7MlGT

In the SARAH trial, sacubitril-valsartan reduced LV dysfunction in patients with anthracylcine related cardiotoxicity @Bocchi @MBittencourtMD @monicaAGrinberg @lukadalech @larimosko https://t.co/Y0kVwwbT1V